Test Price
2,800 AED✅ Home Collection Available
ELOVL4 Gene: Ichthyosis, Spastic Quadriplegia, and Intellectual Disability – Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ELOVL4 للإكثيوزيس، الشلل التشنجي الرباعي والإعاقة الذهنية – اختبار الحمض النووي بتقنية التسلسل الجيني الشامل في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary (ملخص تنفيذي)
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a DHA-licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview
This next‑generation sequencing (NGS) test screens the entire coding region of the ELOVL4 gene to detect variants associated with syndromic ichthyosis, spastic quadriplegia, and intellectual disability. (يقوم هذا الاختبار بالكشف عن الطفرات الجينية في جين ELOVL4 المسبب للإكثيوزيس المتلازمي والشلل التشنجي الرباعي والإعاقة الذهنية)
| Feature | Our Test (ELOVL4 NGS) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | Full coding region + splice sites, >99.9% analytical sensitivity | Limited to known mutation hotspots; may miss novel variants |
| Method | Next‑Generation Sequencing (NGS) with bioinformatic confirmation | Sanger sequencing of selected exons |
| Speed (TAT) | 3–4 Weeks | 5–8 Weeks (often outsourced) |
Physician Insight & Safety Protocol
“As a DHA‑licensed dermatologist and clinical geneticist, I always remind families that this NGS test must be correlated with clinical findings and a comprehensive pedigree. A negative test does not rule out other genetic or environmental factors, and a positive result calls for multidisciplinary management.” – Dr. PRABHAKAR REDDY, DHA License: 61713011.
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic results may influence future therapy choices but never replace current clinical management.
Exclusion Criteria & Emergency Red Flags
- Patient is unwilling/unable to provide informed consent or a legal guardian is unavailable for minors.
- Active skin infection or bleeding diathesis preventing safe sample collection.
- Recent bone marrow transplant or blood transfusion (< 6 weeks) that may adulterate DNA source.
- Emergency Red Flags: New‑onset seizures, loss of ambulation, respiratory distress, or sudden worsening of skin barrier – seek immediate medical attention.
Frequently Asked Questions
1. How long does it take to receive the ELOVL4 genetic test results?
The test is performed using NGS technology and delivers definitive results within 3 to 4 weeks from sample receipt. You will be contacted as soon as the report is ready, and a telephonic post‑test clinical guidance session will be scheduled immediately.
2. هل اختيار عينة الحمض النووي عن طريق شريحة FTA دقيق مثل سحب الدم الكامل؟
نعم، شريحة FTA توفر مصدراً عالي الجودة ومستقراً للحمض النووي وتكافئ دقة عينة الدم الكامل. (Yes, the FTA card provides a high‑quality, stable DNA source and is equivalent in accuracy to a whole blood sample. Our lab validates all sample types for ELOVL4 sequencing.)
3. هل يتطلب الفحص استشارة جينية مسبقة في الإمارات؟
نعم، تتطلب التوجيهات الصادرة عن هيئة الصحة بدبي لعام 2026 جلسة استشارة جينية إلزامية لرسم شجرة العائلة وإعطاء الموافقة المستنيرة. (Yes, the 2026 DHA guidelines mandate a pre‑test genetic counselling session to draw a pedigree chart and obtain informed consent. This ensures the test is interpreted correctly within your family context.)
Pre‑ Information
Clinical history of the patient including systemic involvement, developmental milestones, and family pedigree will be recorded. A mandatory genetic counselling session is required to construct a three‑generation pedigree chart of family members affected by ELOVL4‑related ichthyosis, spastic quadriplegia, and intellectual disability. Sample can be collected as whole blood, extracted DNA, or a dried blood spot on an FTA card.
UAE Regulatory Compliance: This service adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87), the CDS Law 2026 provisions regarding genetic testing in minors, and the UAE Personal Data Protection Law (PDPL). Laboratory operates under DHA Facility License 9834453 and ISO 9001:2015 Certification (Cert: INT/EGQ/2509DA/3139). All genetic data is stored and processed within UAE borders.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians